A detailed history of Janus Henderson Group PLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 23,319 shares of PCRX stock, worth $447,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,319
Previous 698,388 96.66%
Holding current value
$447,724
Previous $20 Million 98.24%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.7 - $28.46 $7.9 Million - $19.2 Million
-675,069 Reduced 96.66%
23,319 $351,000
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $2.46 Million - $3.04 Million
96,328 Added 16.0%
698,388 $20 Million
Q1 2024

May 15, 2024

SELL
$27.7 - $35.48 $54,652 - $70,002
-1,973 Reduced 0.33%
602,060 $17.6 Million
Q4 2023

Feb 14, 2024

BUY
$26.32 - $34.31 $1.75 Million - $2.28 Million
66,330 Added 12.34%
604,033 $20.4 Million
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $5.63 Million - $7.36 Million
183,604 Added 51.85%
537,703 $16.5 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $47.5 $12.1 Million - $15.9 Million
334,292 Added 1687.75%
354,099 $14.2 Million
Q1 2023

May 15, 2023

BUY
$35.53 - $43.38 $389,977 - $476,138
10,976 Added 124.29%
19,807 $808,000
Q4 2022

Feb 14, 2023

BUY
$38.19 - $57.45 $337,255 - $507,340
8,831 New
8,831 $340,000
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $819 - $942
16 Added 0.18%
8,830 $470,000
Q2 2022

Aug 15, 2022

SELL
$51.49 - $81.64 $463 - $734
-9 Reduced 0.1%
8,814 $514,000
Q1 2022

May 16, 2022

SELL
$60.03 - $76.49 $1.85 Million - $2.36 Million
-30,842 Reduced 77.76%
8,823 $674,000
Q4 2021

Feb 14, 2022

SELL
$47.97 - $62.21 $1.07 Million - $1.39 Million
-22,278 Reduced 35.97%
39,665 $2.39 Million
Q3 2021

Nov 16, 2021

SELL
$54.64 - $61.3 $567,764 - $636,968
-10,391 Reduced 14.37%
61,943 $3.47 Million
Q2 2021

Aug 16, 2021

SELL
$59.18 - $69.99 $294,775 - $348,620
-4,981 Reduced 6.44%
72,334 $4.39 Million
Q1 2021

May 17, 2021

BUY
$59.31 - $78.82 $4.59 Million - $6.09 Million
77,315 New
77,315 $5.42 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $880M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.